Association between Fecal Calprotectin and Mucosal Healing in Pediatric Patients with Crohn’s Disease Who Have Achieved Sustained Clinical Remission with Anti-Tumor Necrosis Factor Agents

BACKGROUND/AIMS: Although mucosal healing (MH) is acknowledged as the treatment target in the treat-to-target era, there are limitations on repeated endoscopic examinations, especially in pediatric patients. We aimed to investigate whether fecal calprotectin (FC) could serve as a surrogate marker fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yoo Min, Choi, Sujin, Choe, Byung-Ho, Jang, Hyo-Jeong, Kim, Seung, Koh, Hong, Kim, Eun Sil, Kim, Mi Jin, Choe, Yon Ho, Kang, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761923/
https://www.ncbi.nlm.nih.gov/pubmed/33833135
http://dx.doi.org/10.5009/gnl20300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761923/
https://www.ncbi.nlm.nih.gov/pubmed/33833135
http://dx.doi.org/10.5009/gnl20300

Ejemplares similares